Perennial Advisors, LLC Gilead Sciences, Inc. Transaction History

Perennial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$67.69 - $73.03 $64,170 - $69,232	-948 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $4,760 - $5,201	-75 Reduced 7.33%	948 $65,000
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $13,380 - $15,266	223 Added 27.88%	1,023 $66,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $45,320 - $51,640	800 New	800 $47,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $53,219 - $66,914	-857 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $89,412 - $103,824	-1,236 Reduced 59.05%	857 $66,000
Q1 2020 May 19, 2020	BUY	$62.63 - $80.22 $131,084 - $167,900	2,093 New	2,093 $150,000
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $43,771 - $49,035	-700 Closed	0 $0
Q4 2018 Jan 29, 2019	SELL	$60.54 - $79.0 $12,108 - $15,800	-200 Reduced 22.22%	700 $44,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $14,256 - $15,784	-200 Reduced 18.18%	900 $69,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $14,568 - $17,760	-200 Reduced 15.38%	1,100 $83,000
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $93,743 - $111,111	1,300	1,300 $105,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Perennial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Perennial Advisors, LLC with notifications on news.